877 related articles for article (PubMed ID: 16792748)
1. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
[TBL] [Abstract][Full Text] [Related]
2. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
Kimata H
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221
[TBL] [Abstract][Full Text] [Related]
3. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
Chen L; Overbergh L; Mathieu C; Chan LS
Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
[TBL] [Abstract][Full Text] [Related]
4. Suppression of the Th2 pathway by suplatast tosilate in patients with perennial nasal allergies.
Furukido K; Takeno S; Ueda T; Hirakawa K; Yajin K
Am J Rhinol; 2002; 16(6):329-36. PubMed ID: 12512908
[TBL] [Abstract][Full Text] [Related]
5. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions.
Konishi H; Tsutsui H; Murakami T; Yumikura-Futatsugi S; Yamanaka K; Tanaka M; Iwakura Y; Suzuki N; Takeda K; Akira S; Nakanishi K; Mizutani H
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11340-5. PubMed ID: 12151598
[TBL] [Abstract][Full Text] [Related]
6. [The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis].
Suto H; Mitsuishi K; Hira K; Uchida T; Unno T; Ogawa H; Yoshiike T; Takamori K
Arerugi; 2000 Dec; 49(12):1163-72. PubMed ID: 11197882
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
Yoshihara S; Fukuda H; Arisaka O
Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
[TBL] [Abstract][Full Text] [Related]
8. IL-4/IL-13 antagonist DNA vaccination successfully suppresses Th2 type chronic dermatitis.
Morioka T; Yamanaka K; Mori H; Omoto Y; Tokime K; Kakeda M; Kurokawa I; Gabazza EC; Tsubura A; Yasutomi Y; Mizutani H
Br J Dermatol; 2009 Jun; 160(6):1172-9. PubMed ID: 19416272
[TBL] [Abstract][Full Text] [Related]
9. Improvement of atopic dermatitis in NC/Nga mice by topical application of CpG phosphodiester-ODN.
Kim YS; Kim Y; Lee KJ; Kwon HJ; Kim DS; Kim TY
Int Arch Allergy Immunol; 2007; 144(4):315-24. PubMed ID: 17671391
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of streptococcal preparation OK-432 on atopic dermatitis-like lesions in NC/Nga mice: possible shift from a Th2- to Th1-predominance.
Horiuchi Y; Bae S; Katayama I; Nishioka K
J Dermatol Sci; 2004 Sep; 35(3):187-97. PubMed ID: 15381240
[TBL] [Abstract][Full Text] [Related]
11. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters].
Higashi N; Niimi Y; Aoki M; Fujimoto K; Suzuki K; Numano K; Kawana S
Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038
[TBL] [Abstract][Full Text] [Related]
12. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
[TBL] [Abstract][Full Text] [Related]
13. Suppression of dust mite extract and 2,4-dinitrochlorobenzene-induced atopic dermatitis by the water extract of Lindera obtusiloba.
Choi EJ; Lee S; Kim HH; Singh TS; Choi JK; Choi HG; Suh WM; Lee SH; Kim SH
J Ethnopharmacol; 2011 Sep; 137(1):802-7. PubMed ID: 21762765
[TBL] [Abstract][Full Text] [Related]
14. Sustained exogenous expression of therapeutic levels of IFN-gamma ameliorates atopic dermatitis in NC/Nga mice via Th1 polarization.
Hattori K; Nishikawa M; Watcharanurak K; Ikoma A; Kabashima K; Toyota H; Takahashi Y; Takahashi R; Watanabe Y; Takakura Y
J Immunol; 2010 Mar; 184(5):2729-35. PubMed ID: 20107184
[TBL] [Abstract][Full Text] [Related]
15. Heat-killed bacillus Calmette-Guérin and Mycobacterium kansasii antigen 85B combined vaccination ameliorates dermatitis in a mouse model of atopic dermatitis by inducing regulatory T cells.
Kakeda M; Yamanaka K; Kitagawa H; Tsuda K; Akeda T; Kurokawa I; Gabazza EC; Mizutani H
Br J Dermatol; 2012 May; 166(5):953-63. PubMed ID: 22136598
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.
Neis MM; Peters B; Dreuw A; Wenzel J; Bieber T; Mauch C; Krieg T; Stanzel S; Heinrich PC; Merk HF; Bosio A; Baron JM; Hermanns HM
J Allergy Clin Immunol; 2006 Oct; 118(4):930-7. PubMed ID: 17030248
[TBL] [Abstract][Full Text] [Related]
17. The effects of suplatast tosilate (IPD-1151T) on innate immunity and antigen-presenting cells.
Hsu LW; Yang CH; Goto S; Nakano T; Lai CY; Lin YC; Kao YH; Chen SH; Cheng YF; Jawan B; Chiu KW; Tsao FK; Chen CL
Transpl Immunol; 2007 Nov; 18(2):108-14. PubMed ID: 18005853
[TBL] [Abstract][Full Text] [Related]
18. Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial allergic rhinitis.
Washio Y; Ohashi Y; Tanaka A; Kakinoki Y; Sugiura Y; Sakamoto H; Yamada K; Matsuda M; Uekawa M; Okamoto H; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():126-32. PubMed ID: 9879412
[TBL] [Abstract][Full Text] [Related]
19. Early intervention with suplatast tosilate for prophylaxis of pediatric atopic asthma: a pilot study.
Yoshihara S; Ono M; Yamada Y; Fukuda H; Abe T; Arisaka O
Pediatr Allergy Immunol; 2009 Aug; 20(5):486-92. PubMed ID: 19210644
[TBL] [Abstract][Full Text] [Related]
20. Topical application of an ethanol extract prepared from Illicium verum suppresses atopic dermatitis in NC/Nga mice.
Sung YY; Yang WK; Lee AY; Kim DS; Nho KJ; Kim YS; Kim HK
J Ethnopharmacol; 2012 Oct; 144(1):151-9. PubMed ID: 22971899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]